
Can dolutegravir/lamivudine be just as effective in people with archival M184V/I as it is in everyone else? A new #study published in @CIDJournal gets us as close as we’ve ever been to a firm answer: bit.ly/3MXI4HP #HIV #Research #Medicine

The HIV resource for care providers and the HIV workforce. For the HIV community, check out @TheBodyDotCom

Can dolutegravir/lamivudine be just as effective in people with archival M184V/I as it is in everyone else? A new #study published in @CIDJournal gets us as close as we’ve ever been to a firm answer: bit.ly/3MXI4HP #HIV #Research #Medicine

As people with #HIV live longer on viral suppression, parkinsonism‑like motor symptoms are increasingly recognized and may affect quality of life. A recent review in @TheLancet highlights why awareness of these changes matters for #aging with HIV: bit.ly/46RJM4f

Recorded during a pivotal moment for #HIV care, @UNC_ID's Dr. Wohl unpacks the top #clinical and policy developments shaping the field, and what they mean for prevention, treatment, and equity moving forward. A must-listen for HIV clinicians: bit.ly/40k8Lta #HIVCare

New #data affirm the value of #pneumonia and herpes zoster #vaccination for particular subsets of people living w/ #HIV — and of the continued relevance of these infectious diseases. Dr. Young shares the three key #clinical lessons #HCPs need to know: bit.ly/4sQ96Bc

A two-year #study comparing two forms of #PrEp found small but significant differences in BMD impact. The findings provide a golden opportunity for #HCPs to revisit what we know about BMD, and how we can best approach conversations with our patients: bit.ly/4nMV809 #HIV


#TelePrEP is growing fast. According to a new study in @JAMANetworkOpen, ~19% of U.S. #PrEP users received care virtually in 2024. Dr. Young highlights three key takeaways about scale, access for uninsured/first-time users, and patient preference: bit.ly/3N3ujXG #HIV

As #HIV prevention options expand, choosing the right #PrEP isn’t just about efficacy. In a new interview, Dr. Anu Hazra (@UChicagoMed + @howardbrownhc) explains the best choice is the one that aligns with your patient’s needs, preferences, and lifestyle: bit.ly/3KJPi12

We care deeply for our patients, but who’s caring for #HIV care teams? A new #study shows #resilience alone doesn’t shield care teams from the impact of trauma. Dr. Benjamin Young breaks down what providers need: bit.ly/4oyck8R #MentalHealth #Medicine #HCP #HIVCare

As #HIV providers, we can’t ignore this: Cancer screening rates remain low for Black women with HIV. Engagement in care isn’t enough. Dr. Benjamin Young challenges us to examine our role in closing the gap: bit.ly/3ZBRBXW #Research #Medicine #CancerScreening

Amid rising threats to #HIV #funding and community #health, @prepinblkUS is launching the PrEP in Black America HIV Policy Impact Tracker this spring. What to know: bit.ly/4arzdWF #HIV #HIVCare #CommunityHealth

Could a two-drug combo simplify #HIV treatment? ARTISTRY-1 results are intriguing, but experts urge caution. Dr. Benjamin Young and @BodyProHIV’s Myles Helfand explain: bit.ly/43Q8r7S #HIVCare #ART #HIVResearch

Injectable, twice-yearly #PrEP makes prevention easier, but knowing how to use it matters. @JncherabieMD shares key insights on injectable #lenacapavir, from dosing to how to talk about it with patients: bit.ly/45Cr00N #HIV #HIVPrevention #HIVCare

What do people wish they’d heard after an #HIV diagnosis? One person's reflection shows how small changes in communication can make a big difference: bit.ly/4c85AZz #HIV #Medicine

Many patients with #HIV experience disordered #sleep that’s easy to miss. Drs. Chandiwana and Scheuermaier explain how to recognize distinct HIV-related sleep patterns and when to refer: bit.ly/4aml50R #HIVCare #SleepMedicine

People with substance use face a higher #HIV risk, yet new data show that many treatment settings still don’t offer routine HIV testing, #PrEP, or care services. How can we better integrate these services for the communities who need them most? More: bit.ly/4tpGzTe